Suchergebnisse
Wall Street Bulls Look Optimistic About Abbott (ABT): Should You Buy?
When deciding whether to buy, sell, or hold a stock, investors often rely on analyst recommendations. Media reports about rating changes by these brokerage-firm-employed (or sell-side) analysts
3 Companies Aggressively Raising Dividends While Others Play Defense
Dividend growth stocks may be worth a closer look heading toward the midpoint of 2026, given extreme geopolitical turbulence and concerns about inflation or a recession that are sending skittish
Will Robust Medical Business Performance Fuel ABT's Q1 Earnings?
Abbott Laboratories ABT is slated to report first-quarter 2026 results on April 16, before the opening bell.
The company delivered adjusted earnings per share (EPS) of $1.50 in the last reported
Top Analyst Reports for Microsoft, AbbVie & BHP
Friday, April 17, 2026The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Microsoft
The Zacks Analyst Blog Microsoft, AbbVie, BHP, CBL & Associates Properties and IRIDEX
For Immediate Releases
Chicago, IL – April 20, 2026 – Zacks.com announces the list of stocks and ETFs featured in the Analyst Blog. Every day the Zacks Equity Research analysts discuss the latest